Status:
ACTIVE_NOT_RECRUITING
Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Adjuvant radiotherapy after lumpectomy allows a local long-term control of the order 85 to 95% with a survival rate equivalent to that of the totally mastectomy. The diminution of the local recurrence...
Detailed Description
Patients responding criteria for selection and not objecting to participate in this trial will address the quality of life questionnaires at baseline and during their standard follow-up (1, 6, 12 and ...
Eligibility Criteria
Inclusion
- 1-Patient with breast cancer proved by histology and treated surgically 2. Relevant of adjuvant radiotherapy after partial or total mastectomy with or without lymph node irradiation 3- Age ≥ 18 years 4- Information and no opposition to the patient
Exclusion
- \- Metastatic disease
- \- Patient having another severe disease or uncontrolled which could jeopardize the trial participation
- \- pregnant or breastfeeding woman 4-inability to do follow-up medical care of clinical trial for geographical, social or psychological reasons
Key Trial Info
Start Date :
November 18 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02281149
Start Date
November 18 2014
End Date
December 31 2025
Last Update
June 4 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Léonard de Vinci
Douai, France, 59500
2
Centre Oscar Lambret
Lille, France, 59020